MaaT Pharma
French tech company | Builders Republic
About
Listed clinical-stage biotech developing gut-microbiome therapies for cancer patients — restoring microbial diversity damaged by chemotherapy and antibiotics, with a lead candidate for graft-versus-host disease after stem-cell transplant and programs combining microbiome treatments with immuno-oncology.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Post IPO Equity
- Founded
- 2014
- City
- LYON
- Region
- Auvergne-Rhône-Alpes
- Tracked rounds
- 2
- Amount raised
- 17 M€ raised since 2020
Funding rounds
- Post IPO Equity — 2025
- Extension — 2020
Investors
- bpifrance
- Céleste Management
- SkyViews Life Science